| 1724 |
Dr. Mahendra Pal |
Study of the Nephron Sparing Surgeries done at Tata Memorial Hospital |
REF/2016/12/012814 |
Data Analysis ongoing |
Surgical Oncology |
Urology |
| 3121 |
Dr. Gagan Prakash |
Pilot Study to standardize the technique of Dynamic Sentinel Lymph Node Biopsy in management of penile cancer patients with clinically normal groin |
CTRI/2019/12/022248 |
Data Analysis ongoing |
Surgical Oncology |
Urology |
| 3293 |
Dr. Amit Joshi |
A prospective study to evaluate the Adverse Drug Reactions and to assess quality of life in prostate cancer patients receiving docetaxel in Tata Memorial Centre. |
CTRI/2019/09/021080 |
Active Enrollment ongoing |
Medical Oncology |
Urology |
| 3294 |
Dr. Mahendra Pal |
In Vitro and In Vivo Functions of Cell Surface Estrogen Receptors (csERs) in the Context of Prostate Cancer. |
CTRI/2020/06/025837 |
Active Enrollment ongoing |
Surgical Oncology |
Urology |
| 3329 |
Dr. Vedang Murthy |
Phase III IGRT and SBRT vs IGRT and hypofractionated IMRT for localized intermediate risk prostate cancer |
CTRI/2020/04/024465 |
Accrual completed and follow-up ongoing |
Radiation Oncology |
Urology |
| 3354 |
Dr. Amit Joshi |
A study of factors associated with delayed presentation of patients with Testicular Germ Cell Tumors for seeking specialized care at Tata Memorial Hospital. (DelP-GCT) |
CTRI/2019/09/021336 |
Data Analysis ongoing |
Medical Oncology |
Urology |
| 3410 |
Dr. Amit Joshi |
A Prospective, Observational study to Compare Quality of Life and side effects in patients undergoing Medical versus Surgical Castration in Metastatic Carcinoma of Prostate at Tata Memorial Hospital |
CTRI/2020/03/024111 |
Data Analysis ongoing |
Medical Oncology |
Urology |
| 3446 |
Dr. Nandini Menon |
To assess the efficacy of low dose Abiraterone (250 mg (1 tablet) once daily taken along with food) in comparison to the standard dose Abiraterone (1000 mg (4 tablets) taken in fasting state) in patients with Metastatic Castrate Resistant Prostate Cancer. |
CTRI/2020/08/026967 |
Active Enrollment ongoing |
Medical Oncology |
Urology |
| 3505 |
Dr. Mahendra Pal |
Intravesical BCG: is the urinary bladder ready to receive it? |
CTRI/2022/03/040806 |
Active Enrollment ongoing |
Surgical Oncology |
Urology |
| 3563 |
Dr. Archi Agrawal |
Radionuclide therapy with 177Lu-PSMA plus Abiraterone versus Abiraterone alone in metastatic, hormone-sensitive prostate cancer: a randomized phase 2 trial - REPLASE_x000D_\n |
CTRI/2020/10/028341 |
Active enrollment ongoing |
Nuclear Medicine |
Urology |
| 3676 |
Dr. Amit Joshi |
Translation and Validation of the 'Patient Generated Subjective Global Assessment short form (PG-SGA SF)' of the English metric version 3.22.15 of the Scored Patient Generated Subjective Global Assessment, into Hindi language |
CTRI/2022/03/040927 |
Active enrollment ongoing |
Medical Oncology |
Urology |
| 3730 |
Dr. Kinjalka Ghosh |
Prostate Health Index (PHI) - Is it a Master Key for Diagnosis of Prostate Cancer? |
CTRI/2021/11/038267 |
Active Enrollment ongoing |
Biochemistry |
Urology |
| 3824 |
Dr. Santosh Menon |
Immunohistochemical analysis of LLT1 on prostate cancer biopsy samples |
|
Case review/sample review ongoing (audit studies) |
Pathology |
Urology |
| 3883 |
Dr. Malini Joshi |
Outcome benefits of Opioid Free Anaesthesia in Urological oncological-surgeries- A single centre randomised blinded trial |
CTRI/2022/03/041207 |
Data Analysis ongoing |
Anaesthesia |
Urology |
| 3898 |
Dr. Mahendra Pal |
Patterns of recurrence in surgically treated localised or loco-regional RCC in a tertiary centre. |
|
Case review/sample review ongoing (audit studies) |
Surgical Oncology |
Urology |
| 3906 |
Dr. Venkatesh Rangarajan |
Lesion detection and dosimetry study with 68Ga PSMA and 177Lu PSMA in metastatic clear cell renal cell carcinoma |
|
Active Enrollment ongoing |
Nuclear Medicine |
Urology |
| 3983 |
Dr. Amit Joshi |
A single-arm, open-label Phase 4 study of darolutamide in addition to standard androgen deprivation therapy for participants in Indian with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC) |
CTRI/2022/03/041422 |
Active Enrollment ongoing |
Medical Oncology |
Urology |
| 4002 |
Dr. Mahendra Pal |
An observation study to assess the level of physical activity in Indian patients of prostate cancer who are planned for Androgen deprivation therapy (ADT). |
CTRI/2022/11/047221 |
Active Enrollment ongoing |
Surgical Oncology |
Urology |
| 4033 |
Dr. Manjusha Vagal |
Prospective Surveillance for Penile Cancer-Related Lower Limb lymphedema |
CTRI/2022/12/048335 |
Active Enrollment ongoing |
Occupational Therapy |
Urology |
| 4113 |
Dr. Vanita Noronha |
DAHLIA: Docetaxel with Abiraterone full versus low dose in Hormone Sensitive Advanced Prostate Cancer - Phase III, Non-Inferiority Randomized Control Open Label Trial. |
CTRI/2023/03/050180 |
Active Enrollment ongoing |
Medical Oncology |
Urology |
| 4228 |
Dr. Santosh Menon |
NEON study:A Retrospective analysis of NEurOendocrine Neoplasms of Urinary Tract _x000D_\n_x000D_\n |
|
Case review/sample review ongoing (audit studies) |
Pathology |
Urology |
| 4239 |
Dr. Gagan Prakash |
Protocol No. - 17000139BLC3002 : A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and_x000D_\nSafety of TAR-200 in Combination with Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants with BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) |
CTRI/2023/07/054818 |
Accrual completed and intervention ongoing |
Surgical Oncology |
Urology |
| 4242 |
Dr. Vedang Murthy |
Quality Of Life Measures after Bladder Preservation and Cystectomy: A prospective longitudinal comparative study (QOMPACT)_x000D_\n_x000D_\n |
CTRI/2023/11/059560 |
Active Enrollment ongoing |
Radiation Oncology |
Urology |
| 4282 |
Dr. Santosh Menon |
Micropapillary Urothelial Carcinomas of the Urinary Bladder: A Clinicopathologic 5 year retrospective study at a Tertiary Cancer Care Centre |
|
Publication activities ongoing |
Pathology |
Urology |
| 4333 |
Dr. Santosh Menon |
Histological subtypes of penile squamous cell carcinoma and its correlation with p16INK4a immunohistochemistry, pathological variables and clinical outcomes. |
|
Case review/sample review ongoing (audit studies) |
Pathology |
Urology |
| 4356 |
Dr. Nilesh Sable |
Correlation of histopathologic subtype of RCC and Generation of R.E.N.A.L. nephrometry score from CT imaging using Deep Learning Approach |
|
Approved |
Radio-diagnosis |
Urology |
| 4391 |
Dr. Amit Joshi |
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Adenocarcinoma of the Prostate. |
CTRI/2024/06/068779 |
Active enrollment ongoing |
Medical Oncology |
Urology |
| 4392 |
Dr. Amit Joshi |
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Urothelial Carcinoma (UC) in India. |
CTRI/2024/06/068779 |
Active Enrollment ongoing |
Medical Oncology |
Urology |
| 4434 |
Dr. Priyamvada Maitre |
Clinical outcomes of muscle invasive bladder cancer patients treated with bladder preservation approach |
|
Not started/Not initiated |
Radiation Oncology |
Urology |
| 4523 |
Dr. Gagan Prakash |
APPROACH: Avoiding Pelvic Lymph Node Dissection during Radical Prostatectomy using pre-operative PSMA PET based SUVmax - a multicentric study |
|
Case review/sample review ongoing (audit studies) |
Surgical Oncology |
Urology |
| 4536 |
Dr. Mahendra Pal |
Retrospective study of risk factors for post operative ileus after radical cystectomy ileal conduit at tertiary centre. |
|
Case review/sample review ongoing (audit studies) |
Surgical Oncology |
Urology |
| 4592 |
Dr. Santosh Menon |
Prostate Cancer in Young Men: A Clinico-pathological Study |
|
Approved |
Pathology |
Urology |
| 4615 |
Dr. Gagan Prakash |
Utility of estimating serum PSP94 levels in management of patients with raised PSA in clinical setting: A multicentric study |
CTRI/2024/10/094112 |
Approved |
Surgical Oncology |
Urology |
| 4655 |
Dr. Manjunath Nookala |
Development of an EORTC patient-reported outcome measure (questionnaire module) for renal cell cancer patients (provisional RCC-38): Phase III |
|
Approved |
Clinical Pharmacology |
Urology |
| 4656 |
Dr. Gagan Prakash |
Ambispective Audit of Patients Undergoing Retroperitoneal Lymph Node Dissection for Testicular Germ Cell Tumor |
|
Approved |
Surgical Oncology |
Urology |
| 4770 |
Dr. Minit Shah |
Molecular risk adapted treatment modification in patients with metastatic hormonesensitive prostate cancer. (MAP-PROSTATE) |
CTRI/2025/07/090975 |
Approved |
Medical Oncology |
Urology |
| 4781 |
Dr. Mahendra Pal |
A Retrospective Analysis and External Validation of the MSKCC and Briganti Nomograms for Predicting Lymph Node Involvement in Prostate Carcinoma Among Indian Patients._x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Urology |
| 4830 |
Dr. Santosh Menon |
Comparative study of Manual and AI-algorithms based assessment of prostate biopsies |
|
Approved |
Pathology |
Urology |
| 4872 |
Dr. Venkatesh Rangarajan |
AcTFirst: A phase III, open-label, multi-center, randomized study comparing AAA817+ARPI versus standard of care in adult participants with PSMA-positive metastatic castration resistant prostate cancer . |
|
Approved |
Nuclear Medicine |
Urology |
| 4882 |
Dr. Amandeep Arora |
Outcomes of Robot-Assisted Radical Prostatectomy (RARP) in Lymph Node Positive Prostate Cancer: A Retrospective Study. |
|
Approved |
Surgical Oncology |
Urology |
| 4954 |
Dr. Santosh Menon |
Plasmacytoid urothelial carcinoma of urinary bladder: A clinico-pathological review. |
|
Approved |
Pathology |
Urology |